John J.V. McMurray

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

5.9Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study

Circulation(2023)10.1161/circulationaha.122.063374

Top 7%

3.3DataRank

Top 7%108 citations

John J.V. McMurray, Jan Borén, Araz Rawshani, Elmir Ömerovic, Niklas Berg +8 more

Papers

Driven by 111 papers — median percentile 88. Top paper: “Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes”.

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

JAMA(2020)10.1001/jama.2020.1906

N/A

6.7DataRank · unranked

539 citations

Subodh Verma, Kieran F. Docherty, Silvio E. Inzucchi, Inder S. Anand, Jan Bělohlávek +34 more

Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan

JACC Heart Failure(2020)10.1016/j.jchf.2020.04.008

N/A

5.0DataRank · unranked

142 citations

Pardeep S. Jhund, Brian Claggett, Pooja Dewan, Lars Køber, Mikhail Kosiborod +11 more

Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction

JACC Heart Failure(2020)10.1016/j.jchf.2019.12.001

N/A

4.9DataRank · unranked

142 citations

Rafael Díaz, G. Michael Felker, John J.V. McMurray, Marco Metra, Scott D. Solomon +7 more

Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF

Circulation(2022)10.1161/circulationaha.121.058910

N/A

4.7DataRank · unranked

131 citations

Kieran F. Docherty, Hiddo J.L. Heerspink, Rudolf A. de Boer, Kevin Damman, Silvio E. Inzucchi +16 more

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

European Heart Journal(2021)10.1093/eurheartj/ehab499

N/A

4.2DataRank · unranked

154 citations

Pardeep S. Jhund, Inder S. Anand, Hans‐Dirk Düngen, Carolyn S.P. Lam, Marty Lefkowitz +15 more

Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial

Circulation(2022)10.1161/circulationaha.122.061754

N/A

4.2DataRank · unranked

152 citations

Pardeep S. Jhund, Jan Bělohlávek, Rudolf A. de Boer, Chern‐En Chiang, Akshay S. Desai +22 more

Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction

JACC Heart Failure(2020)10.1016/j.jchf.2020.03.002

N/A

4.1DataRank · unranked

117 citations

Muthiah Vaduganathan, Brian Claggett, Michael R. Zile, Inder S. Anand, Milton Packer +15 more

Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

Nature Medicine(2021)10.1038/s41591-021-01505-4

N/A

3.8DataRank · unranked

134 citations

Sharlene M. Day, Anna Axelsson Raja, Mark W. Russell, Kenneth Zahka, Harry M. Lever +40 more

Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study

Circulation(2023)10.1161/circulationaha.122.063374

Top 7%

3.3DataRank

Top 7%108 citations

John J.V. McMurray, Jan Borén, Araz Rawshani, Elmir Ömerovic, Niklas Berg +8 more

Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2022)10.1001/jamacardio.2022.3750

N/A

2.9DataRank · unranked

67 citations

Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi +12 more

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF

Diabetes Care(2020)10.2337/dc20-1675

N/A

2.7DataRank · unranked

76 citations

Kieran F. Docherty, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski +16 more

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF

Circulation(2021)10.1161/circulationaha.121.053659

N/A

2.5DataRank · unranked

60 citations

Piotr Ponikowski, Kieran F. Docherty, Samvel B. Gasparyan, Michael Böhm, Chern‐En Chiang +16 more

Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction

JAMA Cardiology(2022)10.1001/jamacardio.2022.3736

N/A

1.9DataRank · unranked

61 citations

Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan, Zi Michael Miao, Toru Kondo +11 more

A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction

European Heart Journal(2020)10.1093/eurheartj/ehaa184

N/A

1.9DataRank · unranked

47 citations

Pardeep S. Jhund, Brian Claggett, Milton Packer, J Widimský, Petar Seferović +6 more

Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF

JACC Heart Failure(2020)10.1016/j.jchf.2020.08.014

N/A

1.8DataRank · unranked

42 citations

Faı̈ez Zannad, Brian Claggett, Finnian R. Mc Causland, João Pedro Ferreira, Akshay S. Desai +5 more

Combined Search for the Standard Model Higgs Boson Decaying to abb¯Pair Using the Full CDF Data Set

Physical Review Letters(2012)10.1103/physrevlett.109.111802

Top 12%

1.8DataRank

Top 12%36 citations

B. Álvarez González, S. Amerio, D. Amidei, A. Anastassov, A. Annovi +508 more

Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

Nature Medicine(2022)10.1038/s41591-022-02102-9

N/A

1.7DataRank · unranked

67 citations

James C. Fang, Akshay S. Desai, Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan +19 more

Myocardial Infarction in Heart Failure With Preserved Ejection Fraction

JACC Heart Failure(2020)10.1016/j.jchf.2020.02.007

N/A

1.7DataRank · unranked

32 citations

Muthiah Vaduganathan, Brian Claggett, Jenine E. John, Akshay S. Desai, Eldrin F. Lewis +13 more

Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF

European Journal of Heart Failure(2020)10.1002/ejhf.2083

N/A

1.7DataRank · unranked

48 citations

Kieran F. Docherty, Olof Bengtsson, Rudolf A. de Boer, Akshay S. Desai, Jarosław Dróżdż +19 more

Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

European Heart Journal(2023)10.1093/eurheartj/ehad283

N/A

1.6DataRank · unranked

56 citations

Muthiah Vaduganathan, Brian Claggett, Orly Vardeny, Akshay S. Desai, Pardeep S. Jhund +15 more

Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF

Journal of the American Heart Association(2021)10.1161/jaha.121.021494

N/A

1.6DataRank · unranked

45 citations

Nathaniel M. Hawkins, Pardeep S. Jhund, Margaret M. Redfield, Muthiah Vaduganathan, Akshay S. Desai +14 more

Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM‐HF

Journal of the American Heart Association(2021)10.1161/jaha.120.019238

N/A

1.6DataRank · unranked

52 citations

Leanne Mooney, Pooja Dewan, Akshay S. Desai, Ninian N. Lang, Martin Lefkowitz +12 more

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER

Circulation(2022)10.1161/circulationaha.122.062832

N/A

1.5DataRank · unranked

56 citations

Muthiah Vaduganathan, Brian Claggett, Sheila M. Hegde, Maria Pabón, Ian J. Kulac +22 more

Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JACC Heart Failure(2022)10.1016/j.jchf.2022.08.007

N/A

1.5DataRank · unranked

50 citations

Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, Pardeep S. Jhund, Rudolf A. de Boer +13 more

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

European Heart Journal(2021)10.1093/eurheartj/ehab670

N/A

1.5DataRank · unranked

19544 citations

Marco Metra, Marianna Adamo, Roy S. Gardner, Andreas Baumbach, Michael Böhm +34 more

2013 ACCF/AHA Guideline for the Management of Heart Failure

Journal of the American College of Cardiology(2013)10.1016/j.jacc.2013.05.019

N/A

1.4DataRank · unranked

12610 citations

Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E. Casey, Mark H. Drazner +21 more

Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score

JACC Heart Failure(2022)10.1016/j.jchf.2022.03.009

N/A

1.4DataRank · unranked

29 citations

Pooja Dewan, Ersilia M. DeFilippis, Tor Biering‐Sørensen, Kieran F. Docherty, Pardeep S. Jhund +13 more

Apixaban versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine(2011)10.1056/nejmoa1107039

N/A

1.4DataRank · unranked

8849 citations

John H. Alexander, John J.V. McMurray, Renato D. Lopes, Elaine M. Hylek, Michael Hanna +37 more

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

European Heart Journal(2012)10.1093/eurheartj/ehs092

N/A

1.4DataRank · unranked

8514 citations

ESC Scientific Document Group, Frank Arnold Flachskampf, Z. Reiner, C. Albus, P. Benlian +123 more

Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials

Cardiovascular Diabetology(2022)10.1186/s12933-022-01545-1

N/A

1.3DataRank · unranked

42 citations

Brian Claggett, Muthiah Vaduganathan, Jonathan W. Cunningham, Rasmus Rørth, Alice M. Jackson +10 more

Finerenone in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Rationale and Design of the FINEARTS-HF Trial

European Journal of Heart Failure(2024)10.1002/ejhf.3253

N/A

1.3DataRank · unranked

83 citations

Brian Claggett, Carolyn S.P. Lam, Bertram Pitt, Michele Senni, Sanjiv J. Shah +11 more

Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction

JACC Heart Failure(2022)10.1016/j.jchf.2022.01.018

N/A

1.3DataRank · unranked

45 citations

Ivo Planinc, Brian Claggett, Jonathan W. Cunningham, Davor Miličić, Nancy K. Sweitzer +15 more

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

European Heart Journal(2012)10.1093/eurheartj/ehs104

N/A

1.3DataRank · unranked

6898 citations

J. J. V. McMurray, S. Adamopoulos, S. D. Anker, M. Bohm, V. Falk +103 more

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

European Heart Journal(2012)10.1093/eurheartj/ehs215

N/A

1.3DataRank · unranked

6836 citations

Dan Atar, Luigi P. Badano, Carina Blomstrom Lundqvist, Michael A. Borger, Carlo Di Mario +66 more

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

New England Journal of Medicine(2014)10.1056/nejmoa1409077

N/A

1.3DataRank · unranked

6755 citations

Milton Packer, Akshay S. Desai, Jianjian Gong, Martin P. Lefkowitz, Adel R. Rizkala +8 more

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

European Heart Journal(2016)10.1093/eurheartj/ehw210

N/A

1.3DataRank · unranked

6424 citations

Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei +54 more

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine(2019)10.1056/nejmoa1911303

N/A

1.3DataRank · unranked

5622 citations

Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod, Felipe A. Martinez +43 more

Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial

Circulation Heart Failure(2023)10.1161/circheartfailure.122.010259

N/A

1.3DataRank · unranked

52 citations

Brian Claggett, Marc A. Pfeffer, Christopher B. Granger, Lars Køber, Eldrin F. Lewis +10 more

Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial

Circulation(2023)10.1161/circulationaha.123.066506

N/A

1.3DataRank · unranked

36 citations

Muthiah Vaduganathan, Brian Claggett, Jonathan W. Cunningham, Kieran F. Docherty, Akshay S. Desai +13 more

Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial

The Lancet Diabetes & Endocrinology(2022)10.1016/s2213-8587(22)00308-4

N/A

1.2DataRank · unranked

41 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer +14 more

Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure

Circulation Heart Failure(2020)10.1161/circheartfailure.120.007879

N/A

1.1DataRank · unranked

27 citations

Pooja Dewan, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod +9 more

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

The Lancet(2022)10.1016/s0140-6736(22)01429-5

N/A

1.0DataRank · unranked

942 citations

Kieran F. Docherty, Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez +9 more

Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2023)10.1001/jamacardio.2023.4664

N/A

1.0DataRank · unranked

38 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Orly Vardeny +17 more

Effect of Dapagliflozin on Health Status and Quality of Life Across the Spectrum of Ejection Fraction: Participant-Level Pooled Analysis from the DAPA-HF and DELIVER Trials

European Journal of Heart Failure(2023)10.1002/ejhf.2909

N/A

1.0DataRank · unranked

22 citations

Mikhail Kosiborod, Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, Ian J. Kulac +13 more

Relationship of Dapagliflozin With Serum Sodium

JACC Heart Failure(2022)10.1016/j.jchf.2022.01.019

N/A

0.999DataRank · unranked

31 citations

Kieran F. Docherty, Pardeep S. Jhund, Mark C. Petrie, Silvio E. Inzucchi, Lars Køber +12 more

Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials

Journal of the American Society of Nephrology(2023)10.1681/asn.0000000000000248

N/A

0.995DataRank · unranked

39 citations

Niels Jongs, Glenn M. Chertow, John J.V. McMurray, Clare Arnott, Meg Jardine +11 more

Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

JACC Heart Failure(2021)10.1016/j.jchf.2021.08.006

N/A

0.900DataRank · unranked

49 citations

Modele O. Ogunniyi, Inder S. Anand, Akshay S. Desai, Mirta Díez, Jonathan G. Howlett +17 more

Heart Failure, Chronic Obstructive Pulmonary Disease and Efficacy and Safety of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from DELIVER

European Journal of Heart Failure(2023)10.1002/ejhf.3000

N/A

0.889DataRank · unranked

26 citations

Henri Lu, Toru Kondo, Erasmus Bachus, Rudolf A. de Boer, Silvio E. Inzucchi +8 more

Evidence for a Particle Produced in Association with Weak Bosons and Decaying to a Bottom-Antibottom Quark Pair in Higgs Boson Searches at the Tevatron

Physical Review Letters(2012)10.1103/physrevlett.109.071804

N/A

0.842DataRank · unranked

273 citations

V. M. Abazov, B. Abbott, B. S. Acharya, M. Adams, T. Adams +929 more

The Genomics of Heart Failure: Design and Rationale of the HERMES Consortium

ESC Heart Failure(2021)10.1002/ehf2.13517

Top 24%

0.829DataRank

Top 24%22 citations

Sonia Shah, Honghuang Lin, Tomasz Czuba, Albert Henry, Daniel I. Swerdlow +95 more

Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial

Circulation(2023)10.1161/circulationaha.123.065254

N/A

0.805DataRank · unranked

21 citations

Muthiah Vaduganathan, Senthil Selvaraj, Brian Claggett, Zi Michael Miao, Akshay S. Desai +13 more

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure

Circulation(2025)10.1161/circulationaha.125.076575

N/A

0.794DataRank · unranked

37 citations

Siddharth M. Patel, Paul M. Haller, Abby L. Cange, Michael G. Palazzolo, Andrea Bellavia +23 more

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

Circulation(2024)10.1161/circulationaha.124.069568

N/A

0.770DataRank · unranked

169 citations

Yu Mi Kang, KyungAh Im, Brendon L. Neuen, Stefan D. Anker, Deepak L. Bhatt +24 more

Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—post hoc analyses of the ASCEND-ND and ASCEND-D trials

Nephrology Dialysis Transplantation(2022)10.1093/ndt/gfac342

N/A

0.767DataRank · unranked

11 citations

Finnian R. Mc Causland, Brian Claggett, Christoph Wanner, Andrzej Więcek, Michael B. Atkins +13 more

Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause

JACC Heart Failure(2020)10.1016/j.jchf.2020.06.015

N/A

0.704DataRank · unranked

108 citations

Neal A. Chatterjee, Muthiah Vaduganathan, Brian Claggett, Milton Packer, Akshay S. Desai +8 more

Finerenone According to Frailty in Heart Failure

JAMA Cardiology(2025)10.1001/jamacardio.2025.1775

N/A

0.693DataRank · unranked

14 citations

Pardeep S. Jhund, Alasdair D Henderson, Brian Claggett, Chern‐En Chiang, Gerard C.M. Linssen +18 more

Impact of COVID-19 in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Enrolled in the DELIVER Trial

European Journal of Heart Failure(2023)10.1002/ejhf.3043

N/A

0.691DataRank · unranked

16 citations

Mikhail Kosiborod, Brian Claggett, Zi Michael Miao, Muthiah Vaduganathan, Carolyn S.P. Lam +19 more

Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2023)10.1001/jamacardio.2023.1342

N/A

0.671DataRank · unranked

13 citations

Alvin Chandra, Mikhail Kosiborod, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund +17 more

Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF

JACC Heart Failure(2022)10.1016/j.jchf.2021.09.002

N/A

0.614DataRank · unranked

13 citations

Joanne Simpson, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod +10 more

Finerenone and Atrial Fibrillation in Heart Failure

JAMA Cardiology(2025)10.1001/jamacardio.2025.0848

N/A

0.572DataRank · unranked

17 citations

Alasdair D Henderson, Pardeep S. Jhund, Johann Bauersachs, Ovidiu Chioncel, Brian Claggett +19 more

Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibition According to Left Ventricular Ejection Fraction in DAPA-HF

European Journal of Heart Failure(2020)10.1002/ejhf.1867

N/A

0.557DataRank · unranked

40 citations

Scott D. Solomon, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod +18 more

Sex Differences in Congestive Markers in Patients Hospitalized for Acute Heart Failure

ESC Heart Failure(2021)10.1002/ehf2.13300

N/A

0.544DataRank · unranked

11 citations

Ross T. Campbell, Brian Claggett, Eldrin F. Lewis, John D. Groarke, Kieran F. Docherty +7 more

Health‐related quality of life outcomes in PARAGON‐HF

European Journal of Heart Failure(2022)10.1002/ejhf.2738

N/A

0.515DataRank · unranked

30 citations

Carísi Anne Polanczyk, Brian Claggett, Muthiah Vaduganathan, Milton Packer, Martin Lefkowitz +11 more

Quantifying Treatment Effects in Trials with Multiple Event-Time Outcomes

NEJM Evidence(2022)10.1056/evidoa2200047

N/A

0.470DataRank · unranked

22 citations

Zachary R. McCaw, Lü Tian, John J.V. McMurray, Pardeep S. Jhund, Hajime Uno +4 more

Clinical Implications of Subclinical Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction: The PARAGON-HF Study

European Journal of Heart Failure(2024)10.1002/ejhf.3167

N/A

0.434DataRank · unranked

17 citations

Riccardo M. Inciardi, Brian Claggett, Maja Čikeš, Li Liu, Narayana Prasad +10 more

Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial

Circulation(2023)10.1161/circulationaha.122.062918

N/A

0.405DataRank · unranked

7 citations

Karola Jering, C. Jan Willem Borleffs, Rudolf A. de Boer, Brian Claggett, Akshay S. Desai +15 more

Finerenone, Chronic Obstructive Pulmonary Disease, and Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial

European Journal of Heart Failure(2025)10.1002/ejhf.3661

N/A

0.397DataRank · unranked

11 citations

Pardeep S. Jhund, Alasdair D Henderson, Brian Claggett, Akshay S. Desai, Carolyn S.P. Lam +12 more

Health-Related Quality of Life in Acute Heart Failure: Association Between Patient-Reported Symptoms and Markers of Congestion

European Journal of Heart Failure(2022)10.1002/ejhf.2699

N/A

0.385DataRank · unranked

12 citations

Ross T. Campbell, Brian Claggett, Eldrin F. Lewis, Kieran F. Docherty, Moritz Lindner +5 more

Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics

JAMA Cardiology(2025)10.1001/jamacardio.2025.2551

N/A

0.379DataRank · unranked

9 citations

Pardeep S. Jhund, Alasdair D Henderson, M. Yang, Brian Claggett, Akshay S. Desai +14 more

Dapagliflozin in Patients with Heart Failure and Previous Myocardial Infarction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER

European Journal of Heart Failure(2024)10.1002/ejhf.3184

N/A

0.373DataRank · unranked

11 citations

Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Alberto Foà, Akshay S. Desai +17 more

Relationship Between Cardiac Structure and Function With Renal Function Trajectory and Outcomes in Patients With Heart Failure: Insights From the PARAGON-HF Trial

Circulation Heart Failure(2024)10.1161/circheartfailure.124.011942

N/A

0.358DataRank · unranked

5 citations

Safia Chatur, Sahmin Lee, Riccardo M. Inciardi, Martin Hongieh Abanda, Finnian R. Mc Causland +15 more

Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study

Journal of Cardiac Failure(2024)10.1016/j.cardfail.2023.11.021

N/A

0.358DataRank · unranked

6 citations

Scott Solomon, Marco Metra, John J.V. McMurray, Rafael Díaz, Brian Claggett +15 more

Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2025)10.1001/jamacardio.2025.0860

N/A

0.353DataRank · unranked

7 citations

Pardeep S. Jhund, Muthiah Vaduganathan, Brian Claggett, Jonathan W. Cunningham, Maria Pabón +13 more

Trajectory and correlates of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction: insights from PARADISE-MI

European Heart Journal Acute Cardiovascular Care(2023)10.1093/ehjacc/zuad001

N/A

0.345DataRank · unranked

9 citations

Brian Claggett, Karola Jering, Attila Kovács, Maja Čikeš, Ephraim B. Winzer +9 more

Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction

JACC Heart Failure(2025)10.1016/j.jchf.2025.03.042

N/A

0.325DataRank · unranked

7 citations

John W. Ostrominski, Brian Claggett, Brendon L. Neuen, Iris E. Beldhuis, Jawad H. Butt +14 more

Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure

JACC Heart Failure(2025)10.1016/j.jchf.2025.102706

N/A

0.208DataRank · unranked

3 citations

Jan Bělohlávek, Andrej Dukát, Justin A. Ezekowitz, Sorel Goland, Béla Merkely +14 more

Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction

JACC Heart Failure(2023)10.1016/j.jchf.2022.11.021

N/A

0.208DataRank · unranked

3 citations

Joyce Njoroge, Kirkwood F. Adams, Inder S. Anand, James C. Fang, Félix José Alvarez Ramires +17 more

Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF

European Heart Journal - Cardiovascular Pharmacotherapy(2025)10.1093/ehjcvp/pvaf064

N/A

0.104DataRank · unranked

1 citations

Alasdair D Henderson, Inder S. Anand, Akshay S. Desai, Carolyn S.P. Lam, Aldo P. Maggioni +14 more

Burden of Heart Failure Signs and Symptoms, Prognosis, and Response to Therapy

JACC Heart Failure(2021)10.1016/j.jchf.2021.01.011

N/A

0DataRank · unranked

43 citations

Brian Claggett, Margaret M. Redfield, Sanjiv J. Shah, Inder S. Anand, Felipe A. Martínez +9 more

Cardiovascular-Kidney-Metabolic Overlap in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.05.005

N/A

0DataRank · unranked

42 citations

Brian Claggett, Zi Michael Miao, Finnian R. Mc Causland, Inder S. Anand, Akshay S. Desai +13 more

Beta-Blocker Use and Outcomes in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3383

N/A

0DataRank · unranked

18 citations

Alasdair D Henderson, Li Shen, Toru Kondo, Mingming Yang, Ross T. Campbell +17 more

Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Index: Findings From PARADIGM‐HF and PARAGON‐HF

Journal of the American Heart Association(2024)10.1161/jaha.124.037782

N/A

0DataRank · unranked

14 citations

Mingming Yang, Paolo Tolomeo, Toru Kondo, Li Shen, Pardeep S. Jhund +14 more

Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical Trials

Circulation Heart Failure(2024)10.1161/circheartfailure.124.012514

N/A

0DataRank · unranked

11 citations

Christopher Reeder, Brian Claggett, Pulkit Singh, Emily S. Lau, Shaan Khurshid +14 more

Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trial

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae006

N/A

0DataRank · unranked

15 citations

Guillaume Marquis‐Gravel, Shannon Murphy, Karen P. Alexander, Karen Chiswell, Jennifer B. Green +8 more

Dapagliflozin and Quality of Life Measured Using the EuroQol 5-Dimension Questionnaire in Patients with Heart Failure with Reduced and Mildly Reduced/Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3263

N/A

0DataRank · unranked

14 citations

Toru Kondo, Atefeh Talebi, Pardeep S. Jhund, Kieran F. Docherty, Brian Claggett +15 more

Geographical Variation in Patient Characteristics and Outcomes in Heart Failure with Mildly Reduced and Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3352

N/A

0DataRank · unranked

12 citations

Toru Kondo, Pardeep S. Jhund, Marco A. Alcocer‐Gamba, C. Jan Willem Borleffs, Chern‐En Chiang +17 more

Subcutaneous furosemide in heart failure: a systematic review

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae083

N/A

0DataRank · unranked

8 citations

Mark C. Petrie, Kieran F. Docherty, Matthew M.Y. Lee, John J.V. McMurray, Ross T. Campbell +1 more

Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease

European Heart Journal(2024)10.1093/eurheartj/ehae780

N/A

0DataRank · unranked

8 citations

Mats Christian Højbjerg Lassen, Brian Claggett, Zi Michael Miao, Silvio E. Inzucchi, Kieran F. Docherty +16 more

Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure

International Journal of Cardiology(2024)10.1016/j.ijcard.2024.132036

N/A

0DataRank · unranked

8 citations

Ross T. Campbell, Brian Claggett, Eldrin F. Lewis, Kieran F. Docherty, Matthew M.Y. Lee +7 more

Kidney Status and Events Preceding Death in Heart Failure: A Real-world Nationwide Study

medRxiv(2024)10.1101/2024.10.15.24315570

N/A

0DataRank · unranked

0 citations

Caroline Hartwell Garred, Nicholas Carlson, Emil Loldrup Fosbøl, Mariam Elmegaard, Pardeep S. Jhund +5 more

Worsening Heart Failure Episodes Outside a Hospital Setting in Heart Failure With Preserved Ejection Fraction

JACC Heart Failure(2021)10.1016/j.jchf.2021.01.014

N/A

0DataRank · unranked

40 citations

Jonathan W. Cunningham, Brian Claggett, Finnian Mc Causland, Ebrahim Barkoudah, Peter Finn +8 more

Accelerated and personalized therapy for heart failure with reduced ejection fraction

European Heart Journal(2022)10.1093/eurheartj/ehac210

N/A

0DataRank · unranked

99 citations

Pardeep Singh Jhund, Kieran F. Docherty, Muthiah Vaduganathan, Mark C. Petrie, Akshay S. Desai +7 more

Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials

American Heart Journal(2021)10.1016/j.ahj.2021.02.015

N/A

0DataRank · unranked

6 citations

Søren Lund Kristensen, Muthiah Vaduganathan, Lars Køber, William T. Abraham, Akshay S. Desai +8 more

Benefit of early initiation of disease-modifying therapy in community-based patients with suspected heart failure

European Heart Journal(2025)10.1093/eurheartj/ehaf675

N/A

0DataRank · unranked

11 citations

Benjamin R. Heywood, Antoni Bayés‐Genís, Ross T. Campbell, Alasdair D Henderson, Pardeep S. Jhund +11 more

Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Diabetes Care(2025)10.2337/dc25-2540

N/A

0DataRank · unranked

0 citations

Henri Lu, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund, Alasdair D Henderson +13 more

Finerenone-Related Risk of Hypotension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JACC Heart Failure(2025)10.1016/j.jchf.2025.102779

N/A

0DataRank · unranked

0 citations

Muthiah Vaduganathan, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund, Alasdair D Henderson +14 more

Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis

European Heart Journal - Cardiovascular Pharmacotherapy(2020)10.1093/ehjcvp/pvaa138

N/A

0DataRank · unranked

43 citations

Kieran F. Docherty, Naveed Sattar, Neil Mehta, Ankur Kalra, Amy S. Nowacki +6 more

POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL

Kidney International Reports(2021)10.1016/j.ekir.2021.03.869

N/A

0DataRank · unranked

3 citations

Priya Vart, Niels Jongs, Robert D. Toto, José Luis Górriz, Fan Fan Hou +9 more

Endpoints in Heart Failure Drug Development

JACC Heart Failure(2020)10.1016/j.jchf.2019.12.011

N/A

0DataRank · unranked

50 citations

Naomi Lowy, Norman Stockbridge, Marco Sbolli, Federica Latta, JoAnn Lindenfeld +17 more

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox

European Heart Journal(2023)10.1093/eurheartj/ehad083

N/A

0DataRank · unranked

242 citations

Mark C. Petrie, Pardeep S. Jhund, Naveed Sattar, Akshay S. Desai, Lars Køber +7 more

Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus

Circulation(2020)10.1161/circulationaha.119.041022

N/A

0DataRank · unranked

109 citations

Neha J. Pagidipati, Robert M. Califf, Darren K. McGuire, Jennifer B. Green, Dave DeMets +16 more

Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure

JACC Heart Failure(2022)10.1016/j.jchf.2022.03.004

N/A

0DataRank · unranked

17 citations

Jeroen V. Koomen, Donald E. Kohan, John J.V. McMurray, George L. Bakris, Ricardo Correa‐Rotter +11 more

Optimizing Outcomes in Heart Failure: 2022 and Beyond

ESC Heart Failure(2023)10.1002/ehf2.14363

N/A

0DataRank · unranked

22 citations

Tomas Andersson, Claudia Kaiser‐Albers, Biykem Bozkurt, Ovidiu Chioncel, Andrew J.S. Coats +12 more

Lung ultrasound in acute heart failure: association between quality of life, symptoms and B-lines

European Heart Journal(2021)10.1093/eurheartj/ehab724.1043

N/A

0DataRank · unranked

0 citations

Ross T. Campbell, Brian Claggett, Eldrin F. Lewis, John D. Groarke, Kieran F. Docherty +6 more

Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan

European Journal of Heart Failure(2022)10.1002/ejhf.2722

N/A

0DataRank · unranked

34 citations

Jawad H. Butt, Toru Kondo, Karola Jering, Kieran F. Docherty, Pardeep S. Jhund +16 more

Impact of Multimorbidity on Mortality in Heart Failure with Reduced Ejection Fraction: Which Comorbidities Matter Most? An Analysis of PARADIGM-HF and ATMOSPHERE

European Journal of Heart Failure(2023)10.1002/ejhf.2856

N/A

0DataRank · unranked

19 citations

João Pedro Ferreira, Jawad H. Butt, Mark C. Petrie, William T. Abraham, Akshay S. Desai +11 more

Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model

American Heart Journal(2022)10.1016/j.ahj.2022.03.009

N/A

0DataRank · unranked

23 citations

Ziad Hijazi, Johan Lindbäck, John H. Alexander, Bernard J. Gersh, Christopher B. Granger +8 more

Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial

Diabetes Obesity and Metabolism(2020)10.1111/dom.14252

N/A

0DataRank · unranked

21 citations

Jasper Stevens, George L. Bakris, Ricardo Correa‐Rotter, Fan Fan Hou, Dalane W. Kitzman +9 more

The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF

Journal of Cardiac Failure(2023)10.1016/j.cardfail.2023.08.020

N/A

0DataRank · unranked

7 citations

John J.V. McMurray, Rafael Díaz, G. Michael Felker, Marco Metra, Scott D. Solomon +19 more

Predicting heart failure readmission and all-cause mortality in patients with acute heart failure: a simple predischarge risk score

European Heart Journal(2023)10.1093/eurheartj/ehad655.1095

N/A

0DataRank · unranked

0 citations

Ross T. Campbell, Brian Claggett, Eldrin F. Lewis, Kieran F. Docherty, Matthew M.Y. Lee +7 more

Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics

European Journal of Heart Failure(2021)10.1002/ejhf.2191

N/A

0DataRank · unranked

109 citations

Brian Claggett, Marc A. Pfeffer, Christopher B. Granger, Lars Køber, Eldrin F. Lewis +20 more

John J.V. McMurray

Indexed papers

Top data-sharing exemplar

Papers